Завершено
Фаза III
Беларусь
ЦЕФЕПИМ - AAI101 · Allecra Therapeutics SAS
A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis.